Abnormalities in serotonin systems are presumably linked to various psychiatric disorders including schizophrenia and depression. Medications intended for these disorders aim to either block the reuptake or the degradation of this neurotransmitter. In an alternative approach, efforts have been made to enhance serotonin levels through dietary manipulation of precursor levels with modest clinical success. In the last 30 years, there has been little improvement in the pharmaceutical management of depression, and now is the time to revisit therapeutic strategies for the treatment of this disease. Tryptophan hydroxylase (TPH) catalyzes the first and rate-limiting step in the biosynthesis of serotonin. A recently discovered isoform, TPH2, is responsible for serotonin biosynthesis in the brain. Learning how to activate this enzyme (and its polymorphic versions) may lead to a new, more selective generation of antidepressants, able to regulate the levels of serotonin in the brain with fewer side effects.
AleninaNKikicDTodirasM. (2009) Growth retardation and altered autonomic control in mice lacking brain serotonin. Proc Natl Acad Sci U S A106: 10332–10337.
2.
AndersenOAStokkaAJFlatmarkT. (2003) 2.0A resolution crystal structures of the ternary complexes of human phenylalanine hydroxylase catalytic domain with tetrahydrobiopterin and 3-(2-thienyl)-L-alanine or L-norleucine: substrate specificity and molecular motions related to substrate binding. J Mol Biol333: 747–757.
3.
BirdsallTC (1998) 5-Hydroxytryptophan: a clinically-effective serotonin precursor. Altern Med Rev3: 271–280.
4.
CalvoACSchererTPeyAL. (2010) Effect of pharmacological chaperones on brain tyrosine hydroxylase and tryptophan hydroxylase 2. J Neurochem114: 853–863.
5.
Carkaci-SalliNFlanaganJMMartzMK. (2006) Functional domains of human tryptophan hydroxylase 2 (hTPH2). J Biol Chem281: 28105–28112.
6.
CichonSWingeIMattheisenM. (2008) Brain-specific tryptophan hydroxylase 2 (TPH2): a functional Pro206Ser substitution and variation in the 5′-region are associated with bipolar affective disorder. Hum Mol Genet17: 87–97.
de BodinatCGuardiola-LemaitreBMocaerE. (2010a) Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov9: 628–642.
FitzpatrickPF (1999) Tetrahydropterin-dependent amino acid hydroxylases. Annu Rev Biochem68: 355–381.
14.
GildengersAGWhyteEMDrayerRA. (2008) Medical burden in late-life bipolar and major depressive disorders. Am J Geriatr Psychiatry16: 194–200.
15.
GnadFRenSCoxJ. (2007) PHOSIDA (phosphorylation site database): management, structural and evolutionary investigation, and prediction of phosphosites. Genome Biol8: R250.
16.
GreenbergPEKesslerRCBirnbaumHG. (2003) The economic burden of depression in the United States: how did it change between 1990 and 2000?J Clin Psychiatry64: 1465–1475.
17.
GutknechtLWaiderJKraftS. (2008) Deficiency of brain 5-HT synthesis but serotonergic neuron formation in Tph2 knockout mice. J Neural Transm115: 1127–1132.
18.
HaavikJBlauNThonyB (2008) Mutations in human monoamine-related neurotransmitter pathway genes. Hum Mutat29: 891–902.
19.
HonoreE (2007) The neuronal background K2P channels: focus on TREK1. Nat Rev Neurosci8: 251–261.
20.
HuangZLiuTChattorajA. (2008) Posttranslational regulation of TPH1 is responsible for the nightly surge of 5-HT output in the rat pineal gland. J Pineal Res45: 506–514.
21.
KennedySH (2009) Agomelatine: efficacy at each phase of antidepressant treatment. CNS Drugs23(Suppl. 2): 41–47.
22.
KnolMJTwiskJWBeekmanAT. (2006) Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia49: 837–845.
23.
KobeBJenningsIGHouseCM. (1999) Structural basis of autoregulation of phenylalanine hydroxylase. Nat Struct Biol6: 442–448.
24.
KrishnanVNestlerEJ (2008) The molecular neurobiology of depression. Nature455: 894–902.
25.
KuhnDMSakowskiSAGeddesTJ. (2007) Phosphorylation and activation of tryptophan hydroxylase 2: identification of serine-19 as the substrate site for calcium, calmodulin-dependent protein kinase II. J Neurochem103: 1567–1573.
26.
KumerSCVranaKE (1996) Intricate regulation of tyrosine hydroxylase activity and gene expression. J Neurochem67: 443–462.
27.
LiJDangottLJFitzpatrickPF (2010) Regulation of phenylalanine hydroxylase: conformational changes upon phenylalanine binding detected by hydrogen/deuterium exchange and mass spectrometry. Biochemistry49: 3327–3335.
28.
LicinioJWongML (2005) Depression, antidepressants and suicidality: a critical appraisal. Nat Rev Drug Discov4: 165–171.
29.
LinYMChaoSCChenTM. (2007) Association of functional polymorphisms of the human tryptophan hydroxylase 2 gene with risk for bipolar disorder in Han Chinese. Arch Gen Psychiatry64: 1015–1024.
30.
LinYMKoHCChangFM. (2009) Population-specific functional variant of the TPH2 gene 2755C>A polymorphism contributes risk association to major depression and anxiety in Chinese peripartum women. Arch Womens Ment Health12: 401–408.
31.
MarkusCR (2008) Dietary amino acids and brain serotonin function; implications for stress-related affective changes. Neuromolecular Med10: 247–258.
32.
MarrRARockensteinEMukherjeeA. (2003) Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci23: 1992–1996.
33.
MatthesSMosienkoVBashammakhS. (2010) Tryptophan hydroxylase as novel target for the treatment of depressive disorders. Pharmacology85: 95–109.
34.
McKinneyJKnappskogPMHaavikJ (2005) Different properties of the central and peripheral forms of human tryptophan hydroxylase. J Neurochem92: 311–320.
MurphyKLZhangXGainetdinovRR. (2008) A regulatory domain in the N terminus of tryptophan hydroxylase 2 controls enzyme expression. J Biol Chem283: 13216–13224.
39.
MusselmanDLBetanELarsenH. (2003) Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry54: 317–329.
40.
NuttDJ (2006) The role of dopamine and norepinephrine in depression and antidepressant treatment. J Clin Psychiatry67(Suppl. 6): 3–8.
41.
PatelPDPontrelloCBurkeS (2004) Robust and tissue-specific expression of TPH2 versus TPH1 in rat raphe and pineal gland. Biol Psychiatry55: 428–433.
42.
PincusHAPettitAR (2001) The societal costs of chronic major depression. J Clin Psychiatry62(Suppl. 6): 5–9.
43.
Plazas-MayorcaMDVranaKE (2010) Proteomic investigation of epigenetics in neuropsychiatric disorders: a missing link between genetics and behavior?J Proteome Res10: 58–65.
SavelievaKVZhaoSPogorelovVM. (2008) Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants. PLoS One3: e3301.
46.
SpeddingMJayTCostaeSilvaJ. (2005) A pathophysiological paradigm for the therapy of psychiatric disease. Nat Rev Drug Discov4: 467–476.
47.
TurnerEHLoftisJMBlackwellAD (2006) Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacol Ther109: 325–338.
48.
van WijngaardenBKoeterMKnappM. (2009) Caring for people with depression or with schizophrenia: are the consequences different?Psychiatry Res169: 62–69.
WaltherDJPeterJUBashammakhS. (2003) Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science299: 76.
51.
WangLErlandsenHHaavikJ. (2002) Three-dimensional structure of human tryptophan hydroxylase and its implications for the biosynthesis of the neurotransmitters serotonin and melatonin. Biochemistry41: 12569–12574.
52.
WindahlMSPetersenCRChristensenHE. (2008) Crystal structure of tryptophan hydroxylase with bound amino acid substrate. Biochemistry47: 12087–12094.
53.
WingeIMcKinneyJAKnappskogPM. (2007) Characterization of wild-type and mutant forms of human tryptophan hydroxylase 2. J Neurochem100: 1648–1657.
54.
WingeIMcKinneyJAYingM. (2008) Activation and stabilization of human tryptophan hydroxylase 2 by phosphorylation and 14-3-3 binding. Biochem J410: 195–204.
55.
WongDTPerryKWBymasterFP (2005) Case history: the discovery of fluoxetine hydrochloride (Prozac). Nat Rev Drug Discov4: 764–774.
56.
WongMLLicinioJ (2004) From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nat Rev Drug Discov3: 136–151.
57.
WurtmanRJ (1986) Ways that foods can affect the brain. Nutr Rev44(Suppl.): 2–6.
58.
WurtmanRJ (1988) Presynaptic control of Release of Amine Neurotransmitters by Precursor Levels. News Physiol Sci3: 158–163.
YoungSNLeytonM (2002) The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels. Pharmacol Biochem Behav71: 857–865.
61.
ZhangXBeaulieuJMGainetdinovRR. (2006) Functional polymorphisms of the brain serotonin synthesizing enzyme tryptophan hydroxylase-2. Cell Mol Life Sci63: 6–11.
